Patrick Holt bought $16k of AMRN
President and CEO at AMARIN CORP PLC\UK. 14,426 shares at an average of $1.09, traded Jan 22, 2024, filed Jan 24, 2024.
Score components
- +25RoleCEO
- 0Trade size$16k at market
- 0Relative to holdingsHoldings up 4.8%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-007006, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 22, 2024 | POpen-market purchase Ordinary Shares | +14,426 | $1.09 | $16k | 314,426 | Jan 24, 2024 |
Related signals
Other insiders at AMARIN CORP PLC\UK and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | AMARIN CORP PLC\UK | Steven B Ketchum Chief Scientific Officer | $27k 34,131 shares | -6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.